Skip to main navigation Skip to search Skip to main content

Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways

  • Tyler D. Huber
  • , Fengbin Wang
  • , Shanteri Singh
  • , Brooke R. Johnson
  • , Jianjun Zhang
  • , Manjula Sunkara
  • , Steven G. Van Lanen
  • , Andrew J. Morris
  • , George N. Phillips
  • , Jon S. Thorson

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

S-adenosyl-l-methionine (AdoMet) is an essential enzyme cosubstrate in fundamental biology with an expanding range of biocatalytic and therapeutic applications. We report the design, synthesis, and evaluation of stable, functional AdoMet isosteres that are resistant to the primary contributors to AdoMet degradation (depurination, intramolecular cyclization, and sulfonium epimerization). Corresponding biochemical and structural studies demonstrate the AdoMet surrogates to serve as competent enzyme cosubstrates and to bind a prototypical class I model methyltransferase (DnrK) in a manner nearly identical to AdoMet. Given this conservation in function and molecular recognition, the isosteres presented are anticipated to serve as useful surrogates in other AdoMet-dependent processes and may also be resistant to, and/or potentially even inhibit, other therapeutically relevant AdoMet-dependent metabolic transformations (such as the validated drug target AdoMet decarboxylase). This work also highlights the ability of the prototypical class I model methyltransferase DnrK to accept non-native surrogate acceptors as an enabling feature of a new high-throughput methyltransferase assay.

Original languageEnglish
Pages (from-to)2484-2491
Number of pages8
JournalACS Chemical Biology
Volume11
Issue number9
DOIs
StatePublished - Sep 16 2016

Bibliographical note

Publisher Copyright:
© 2016 American Chemical Society.

Funding

This work was supported in part by the National Institutes of Health Protein Structure Initiative (U01 GM098248, G.N.P.,J.), National Institutes of Health R37 AI52188 (J.S.T.), National Institutes of Health GM109456 (G.N.P.,J.), the National Center f o r Advancing Translational Sciences (UL1TR000117), and the University of Kentucky College of Pharmacy and Markey Cancer Center. We also thank the University of Kentucky Mass Spectrometry Facility (ASTeCC) for HRMS support; the staff at the LS-CAT, SBC-CAT, and GM/CA beamline at the Advanced Photo Source for help in conducting trial attempts and collecting the diffraction data; and K. A. Shaaban (University of Kentucky Center for Pharmaceutical Research and Innovation) for consultation.

FundersFunder number
National Institutes of Health Protein Structure InitiativeU01 GM098248
Center for Pharmaceutical Research and Innovation, University of Kentucky
University of Kentucky College of Pharmacy
University of Kentucky Mass Spectrometry Facility
National Institutes of Health (NIH)R37 AI52188
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical SciencesR01GM109456
National Center for Advancing Translational Sciences (NCATS)UL1TR000117
University of Kentucky Markey Comprehensive Cancer Center

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Medicine

    Fingerprint

    Dive into the research topics of 'Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways'. Together they form a unique fingerprint.

    Cite this